Studies addressing the relationship between peripheral blood CD4 + T cells, CD8 + T cells, Treg cells, and B cells and the effectiveness and progression-free survival of immunotherapy for advanced gastric cancer are lacking. This evidence concerns the gene CD8A and gastric cancer.